Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(15 sites)

Spain

Research Site, A Coruña

Research Site, Badajoz

Research Site, Barakaldo

Research Site, Barcelona

Research Site, Jerez de la Frontera

Research Site, Madrid

Research Site, Málaga

Research Site, Oviedo

Research Site, Santander

Research Site, Seville

Research Site, Valencia

Research Site, Zaragoza